IMMU-28. DEFINING MOLECULAR MECHANISMS OF RESISTANCE TO GLIOBLASTOMA (GBM) IMMUNITY USING A NOVEL CRISPR/CAS9 IN VIVO LOSS-OF-FUNCTION SCREENING PLATFORM
Neagu, Martha R, Speranza, Maria Carmela, Manguso, Robert T, Lawler, Sean E, Freeman, Gordon J, Doench, John, Sharpe, Arlene H, Haining, W NicholasVolume:
19
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nox168.486
Date:
November, 2017
File:
PDF, 86 KB
2017